Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Inhibrx Biosciences (INBX) Gross Profit: 2023-2024

Historic Gross Profit for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $200,000.

  • Inhibrx Biosciences' Gross Profit was N/A to -$3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.9 million, marking a year-over-year change of. This contributed to the annual value of $200,000 for FY2024, which is 88.89% down from last year.
  • Latest data reveals that Inhibrx Biosciences reported Gross Profit of $200,000 as of FY2024, which was down 88.89% from $1.8 million recorded in FY2023.
  • Inhibrx Biosciences' 5-year Gross Profit high stood at $1.8 million for FY2023, and its period low was $200,000 during FY2024.
  • Over the past 2 years, Inhibrx Biosciences' median Gross Profit value was $1.0 million (recorded in 2023), while the average stood at $1.0 million.
  • Data for Inhibrx Biosciences' Gross Profit shows a maximum YoY plummeted of 88.89% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Inhibrx Biosciences' Gross Profit stood at $1.8 million in 2023, then plummeted by 88.89% to $200,000 in 2024.